Multiple sclerosis affects millions of people worldwide, and many patients are researching whether stem cell therapy may help slow progression, reduce relapse frequency, or support quality of life. This article explores what the current evidence suggests, what patients should realistically expect, and how a physician-guided regenerative protocol may be designed for appropriately selected candidates.